Grafted human-induced pluripotent stem cells-derived oligodendrocyte progenitor cells combined with human umbilical vein endothelial cells contribute to functional recovery following spinal cord injury

Qian Li,Sumei Liu,Tianqi Zheng,Mo Li,Boling Qi,Liping Zhou,Bochao Liu,Dan Ma,Chao Zhao,Zhiguo Chen

DOI: https://doi.org/10.1186/s13287-024-03651-1

2024-02-08

Stem Cell Research & Therapy

Abstract:Spinal cord injury (SCI) is a devastating disease that causes extensive damage to oligodendrocytes and neurons leading to demyelination and axonal degeneration. In this study, we co-transplanted cell grafts containing oligodendrocyte progenitor cells (OPCs) derived from human-induced pluripotent stem cells (iPSCs) combined with human umbilical vein endothelial cells (HUVECs), which were reported to promote OPCs survival and migration, into rat contusion models to promote functional recovery after SCI.

cell biology,medicine, research & experimental,cell & tissue engineering

What problem does this paper attempt to address?

This paper aims to address the severe sensory and motor dysfunction caused by spinal cord injury (SCI). Specifically, the authors attempt to promote functional recovery after injury by co-transplanting oligodendrocyte precursor cells (OPCs) derived from induced pluripotent stem cells (iPSCs) with human umbilical vein endothelial cells (HUVECs) into a rat model of spinal cord injury. The study found that HUVECs could promote the proliferation, migration, and survival of OPCs, and the co-transplantation group showed significant effects in sensory and motor function recovery, particularly in sensory function recovery, compared to the group transplanted with OPCs alone. These findings provide new insights into the research on spinal cord injury.